NDC 64764-171 – Dexilant

Dexlansoprazole 30 mg/1 · Capsule, Delayed Release · Oral

Human Prescription Drug

Product NDC64764-171

Product details

Brand name
Dexilant
Generic name
Dexlansoprazole
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
Capsule, Delayed Release
Route
Oral
Marketing category
NDA · NDA022287
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Proton Pump Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Dexilant →

Package NDC codes (7)

Package NDCDescriptionSince
64764-171-007 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-00)Apr 12, 2010
64764-171-015 BLISTER PACK in 1 TRAY (64764-171-01) / 4 CAPSULE, DELAYED RELEASE in 1 BLISTER PACKApr 12, 2010
64764-171-031 BOTTLE in 1 CARTON (64764-171-03) / 5 CAPSULE, DELAYED RELEASE in 1 BOTTLEApr 12, 2010
64764-171-1110 BLISTER PACK in 1 CARTON (64764-171-11) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACKApr 12, 2010
64764-171-191000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-19)Apr 12, 2010
64764-171-3030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-30)Apr 12, 2010
64764-171-9090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-90)Apr 12, 2010

Other Dexilant products